Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205361 | SCV000260081 | benign | Long QT syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000246733 | SCV000318515 | benign | Cardiovascular phenotype | 2016-06-14 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance;Seen in trans with a mutation or in homozygous state in individual without severe disease for that gene |
Eurofins Ntd Llc |
RCV000374014 | SCV000337384 | benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000717686 | SCV000848542 | benign | History of neurodevelopmental disorder | 2016-06-14 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance;Seen in trans with a mutation or in homozygous state in individual without severe disease for that gene |
ARUP Laboratories, |
RCV001711167 | SCV001473633 | benign | not provided | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711167 | SCV001945176 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003915034 | SCV004734841 | benign | CACNA1C-related disorder | 2020-01-13 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |